НовостиBenzingaOppenheimer Maintains Outperform on BridgeBio Oncology, Lowers Price Target to $16 Oppenheimer Maintains Outperform on BridgeBio Oncology, Lowers Price Target to $16 Benzinga 2026.10.20 18:12 (GMT+0) Открыть на Benzinga Другие новости